Last SFr.12.00 CHF
Change Today -0.65 / -5.14%
Volume 54.0K
LIFE On Other Exchanges
SIX Swiss Ex
As of 11:43 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

lifewatch ag-reg (LIFE) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/4/15 - SFr.13.65
52 Week Low
08/8/14 - SFr.7.78
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LIFEWATCH AG-REG (LIFE)

Related News

No related news articles were found.

lifewatch ag-reg (LIFE) Related Businessweek News

No Related Businessweek News Found

lifewatch ag-reg (LIFE) Details

LifeWatch AG, a healthcare technology and solution company, provides telehealth systems and wireless remote patient monitoring services in the United States, Canada, Europe, and Asia. The company operates in Sale of Systems, Lifewatch V, and Services segments. It offers ambulatory cardiac telemetry (ACT), an automatically activated system that provides ECG information; LifeWatch cardiac event monitoring services; LifeStar AF express auto-detect looping monitor that records the heart rhythm and saves the pre-event portion of the ECG; explorer looping monitor, which records a patient's ECG; and non-looping cardiac event monitors. The company also provides Digitrack plus digital holter, a lightweight compact device for ECG recording; clinical research services; LifeWatch connect, a Web-based clinical management solution that streamlines enrolling, reporting, overreading, and ordering of supplies for arrhythmia monitoring services; and NiteWatch home sleep testing service, a prescription service for unattended sleep monitoring of patients with suspected obstructive sleep apnea. In addition, it offers PMP4 wireless healthcare system that provides tools to screen, monitor, and manage general consumer health, high-risk and chronically ill patients, and the wellness and fitness communities; and ACT wireless cardiac telemetry systems for remote arrhythmia monitoring. Further, LifeWatch AG offers cardiology products, such as SelfCheck ECG monitors and weight scales; pulmonology products comprising spiro pro spirometers and oxy pro pulse oximeters; diabetes products; CG-900P, a fetal maternal monitor; and hypertension products, such as Easy2Check and blood pressure devices. The company was formerly known as Card Guard AG and changed its name to LifeWatch AG in May 2009. LifeWatch AG was incorporated in 2001 and is headquartered in Neuhausen am Rheinfall, Switzerland.

561 Employees
Last Reported Date: 08/20/14
Founded in 2001

lifewatch ag-reg (LIFE) Top Compensated Officers

Co-Founder and Director
Total Annual Compensation: SFr.1.2M
Compensation as of Fiscal Year 2013.

lifewatch ag-reg (LIFE) Key Developments

LifeWatch AG Receives FDA 510(K) Clearance for its Vital Signs Patch

LifeWatch AG announced that it has received 510(k) clearance from the FDA (U.S. Food and Drug Administration) for its Vital Signs Patch (VSP). The VSP is an easy-to-use sensor worn on a patient's upper chest. It is intended to be used on adult patients in a clinical environment for the continuous, non-invasive monitoring of ECG, Heart Rate, respiration rate, surface temperature, and arterial blood oxygen saturation (intended use group adults 21 and above), when prescribed by a physician or other qualified healthcare professional. LifeWatch expects to launch the VSP in third quarter of 2015.

LifeWatch AG Announces Management Changes

The Board of Directors of LifeWatch AG has appointed Stefan Vogt as Chief Commercial Officer effective January 1, 2015. Stefan Vogt will be based in Switzerland and be responsible for Global Sales and Marketing, including the development of international business, as well as mHealth initiatives. Stefan Vogt, who is currently interim head of Global Sales, will also continue to fulfill this role until a suitable replacement has been found. The company also announced that, following over 6 years with the company, Yair Tal, President mHealth, has decided to leave in order to pursue a new opportunity.

LifeWatch AG Announces Earnings Results for the First Half of 2014; Provides Earnings Guidance for the Year 2014

LifeWatch AG announced earnings results for the first half of 2014. For the period, the company reported LBITDA of USD 1.52 million compared to EBITDA of USD 4.32 million a year ago. LBIT was USD 4.13 million compared to EBIT of USD 2.71 million a year ago. Higher expenses resulted in a net loss of USD 4.72 million compared to net profit of USD 8.8 million a year ago. In total, revenues surged by 10.2% to USD 48.12 million in the first six months of 2014, compared to USD 43.68 million in the first half of 2013. 99% of revenues were generated by its US-based subsidiary. Basic loss per share was USD 0.36 compared to basic earnings per share of USD 0.68 a year ago. Net cash outflow was USD 3.92 million compared to net cash inflow of USD 4.97 million a year ago. Adjusted EBITDA was USD 1.45 million, adjusted LBIT was USD 1.16 million and adjusted net loss was USD 1.75 million. For the year 2014, based on the on-going operational improvements and a more focused sales approach a turnover in excess of USD 100 million and a positive operating result is targeted.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LIFE:SW SFr.12.00 CHF -0.65

LIFE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $45.28 USD -1.03
BioTelemetry Inc $10.43 USD -0.0786
CardioComm Solutions Inc C$0.09 CAD +0.02
SHL TeleMedicine Ltd SFr.8.16 CHF -0.14
View Industry Companies

Industry Analysis


Industry Average

Valuation LIFE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 4.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIFEWATCH AG-REG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at